SUBSCRIBE
SUBSCRIBE

Phase I

Drug Development
Scientists Highlight the Hopes and Fears of Cellectis’ CAR-T
January 26, 2017
 · 
1 min read
Drug Development
Novartis AG Shows Off 13 Potential Blockbusters in Pipeline
January 25, 2017
 · 
1 min read
JPM17: Why the Key to Gene Therapy Could be in an Old Bay Area Warehouse
Drug Development
JPM17: Why the Key to Gene Therapy Could be in an Old Bay Area Warehouse
January 13, 2017
 · 
2 min read
JPM17: Why the Key to Gene Therapy Could be in an Old Bay Area Warehouse
Drug Development
JPM17: Secretive Moderna Finally Unveils Pipeline, Financials
January 10, 2017
 · 
3 min read
3 Biotechs That Could be Taken Out This Quarter
Drug Development
Fortress Biotech Surged After Reporting Big Success With CAR-T Cancer Approach
December 29, 2016
 · 
2 min read
What You Missed: Nippon Fine Chemical Formed Human Barricade to Stop FDA Employee
Drug Development
4 Fatal Deaths in Seattle Genetics’ Early-Stage Trials of AML Drug
December 27, 2016
 · 
2 min read
Boston Scientific Commits to 10 More Years in SoCal Space, Plans to Hire
Drug Development
Bay Area’s CBT Pharma Plans to Launch 2 Phase I Trials in 2017
December 22, 2016
 · 
3 min read
No Looking Back: Cellectis Preps for Cutting-Edge 'Off-the-Shelf' CAR-T Trial
Drug Development
New York’s Cellectis Looks to 2017 for Clinical Trials of AML Treatment
December 15, 2016
 · 
3 min read
Drug Development
3 Drugs Heading To The FDA Soon
December 12, 2016
 · 
1 min read
Proteostasis and Roche Diagnostics Ink Huge Space in New Boston Hub
Drug Development
3 Biotechs That Could Peak in 2017
December 9, 2016
 · 
3 min read
Load More
PRESS RELEASES
Drug Development
BioInvent and Transgene Report Positive Phase 1a Data on Oncolytic Virus BT-001 in Solid Tumors
May 25, 2023
 · 
8 min read
Business
Transgene and BioInvent Report Positive Phase Ia Data on Oncolytic Virus BT-001 in Solid Tumors
May 25, 2023
 · 
7 min read
Drug Development
Peptilogics Reports Positive 90-Day Top Line Interim Data From Phase 1b Trial of PLG0206 in Patients With Periprosthetic Joint Infection (PJI)
May 24, 2023
 · 
5 min read
Drug Development
Lassen Therapeutics Presents Phase I Data on LASN01, an IL-11 Receptor-Blocking Antibody for Treatment of Pulmonary Fibrosis, at the American Thoracic Society 2023 Annual Meeting
May 24, 2023
 · 
2 min read
Drug Development
4DMT to Present Interim Data from 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibrosis Lung Disease at the European Cystic Fibrosis Society (ECFS) 46th Annual Meeting
May 24, 2023
 · 
7 min read
Drug Development
Immutep Announces Promising New Clinical Data from Triple Combination Therapy in INSIGHT-003 Trial
May 24, 2023
 · 
5 min read
Drug Development
Cybin Initiates First-in-Human Dosing of CYB004 in Phase 1 Clinical Trial
May 24, 2023
 · 
8 min read
Drug Development
Curium Announces Last Patient Enrolled in Their Phase 1/2 SOLAR Clinical Trial Imaging Men with Histologically-Proven Metastatic Prostate Cancer Using Copper Cu 64 PSMA I&T.
May 23, 2023
 · 
2 min read
Drug Development
HILLHURST BIOPHARMACEUTICALS ANNOUNCES COMPLETION OF LAST PATIENT LAST VISIT IN PHASE 1 CLINICAL TRIAL OF HBI-002
May 23, 2023
 · 
2 min read
Drug Development
MEI Pharma Announces Update of Ongoing Phase 1 Study Evaluating Oral CDK9 Inhibitor Voruciclib Alone and in Combination with Venetoclax in Patients with Acute Myeloid Leukemia or B-Cell Malignancies
May 23, 2023
 · 
10 min read
Drug Development
PharmAbcine Receives IND Approval from the Korean MFDS for Phase I Clinical Trial of Its Novel TIE2 Agonistic Antibody in nAMD
May 23, 2023
 · 
4 min read
Drug Development
Wave Life Sciences Announces Topline Results from Phase 1b/2a FOCUS-C9 Study of WVE-004 for C9orf72-associated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
May 23, 2023
 · 
10 min read
Business
Verge Genomics to Incorporate Emerald Digital Health Technology into its ALS Phase 1b Proof-of-Concept Clinical Trial
May 23, 2023
 · 
4 min read
Drug Development
Minghui Pharmaceutical Inc. Announces First-in-Human Dose of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody in Phase 1a Healthy Volunteer Study
May 23, 2023
 · 
4 min read
Drug Development
Zentalis to Host Investor Call to Provide Clinical Update with Safety, Pharmacology, and Efficacy Results for Azenosertib Monotherapy and Development Plans for Monotherapy and Chemotherapy Combinations
May 23, 2023
 · 
5 min read
Drug Development
AnaMar Announces Positive Phase I Data for its Phase II Ready Compound AM1476 for Treating Fibrosis
May 23, 2023
 · 
4 min read
Drug Development
Spago Nanomedical has Submitted Application to Start Tumorad(R) Clinical Phase I/IIa Study
May 23, 2023
 · 
2 min read
Drug Development
Icosavax Announces Positive Topline Interim Phase 1 Results for Bivalent VLP Vaccine Candidate IVX-A12 Against RSV and hMPV in Older Adults
May 22, 2023
 · 
10 min read
Drug Development
HiberCell Doses First Patient in Phase 1b Study Exploring Novel Combination of Odetiglucan and CD40 Agonistic Monoclonal Antibody (CDX-1140) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) in the Maintenance Setting
May 22, 2023
 · 
4 min read
Drug Development
Acepodia Announces First Patient Dosed in Phase 1 Clinical Trial of ACE1831, an Anti-CD20 Armed Allogeneic Gamma Delta T-cell Therapy in Development to Treat Patients with Non-Hodgkin’s Lymphoma
May 22, 2023
 · 
3 min read
Load More